|
|
|
|
| LEADER |
05609nam a22004815i 4500 |
| 001 |
978-3-211-73574-9 |
| 003 |
DE-He213 |
| 005 |
20151204171429.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2007 au | s |||| 0|eng d |
| 020 |
|
|
|a 9783211735749
|9 978-3-211-73574-9
|
| 024 |
7 |
|
|a 10.1007/978-3-211-73574-9
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC346-429.2
|
| 072 |
|
7 |
|a MJN
|2 bicssc
|
| 072 |
|
7 |
|a MED056000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.8
|2 23
|
| 245 |
1 |
0 |
|a Neuropsychiatric Disorders An Integrative Approach
|h [electronic resource] /
|c edited by M. Gerlach, Jürgen Deckert, K. Double, E. Koutsilieri.
|
| 264 |
|
1 |
|a Vienna :
|b Springer Vienna,
|c 2007.
|
| 300 |
|
|
|a IX, 341 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Journal of Neural Transmission. Supplementa ;
|v 72
|
| 505 |
0 |
|
|a The meeting of minds and times with Peter Riederer: an appreciation -- Succi nervorum: a brief history of neurochemistry -- Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y -- Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain -- Lipid content determines aggregation of neuromelanin granules in vitro -- Hydrogen peroxide is a true first messenger -- The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders -- Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis -- Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway -- Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals -- Animal models in neurodegenerative diseases -- Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study -- Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture -- Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects -- Neuroprotection by propargylamines in Parkinson’s disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers -- Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson’s disease -- Low dose methylphenidate improves freezing in advanced Parkinson’s disease during off-state -- The long-term effects of the neurotoxin l-trichloromethyl-1,2,3,4-tetrahydro-?-carboline (TaClo) on cognitive performance in rats -- Observations on the cortical silent period in Parkinson’s disease -- CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity -- Pharmacokinetic studies of (—)-deprenyl and some of its metabolites in mouse -- Serum lipoprotein profile and APOE genotype in Alzheimer’s disease -- VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly -- ?-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis -- Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein -- Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer’s disease -- Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease -- Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach -- Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus -- Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods -- Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder -- Therapeutic drug monitoring of antidepressants — clinical aspects -- The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view -- Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia -- Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice -- FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample -- Impaired cortical inhibition in adult ADHD patients: a study with transcranial magnetic stimulation* -- Association of Parkinson’s disease with symptoms of attention deficit hyperactivity disorder in childhood -- Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection -- Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis -- Neural stem cell transplantation in a model of fetal alcohol effects.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Neurology.
|
| 650 |
|
0 |
|a Clinical psychology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Clinical Psychology.
|
| 700 |
1 |
|
|a Gerlach, M.
|e editor.
|
| 700 |
1 |
|
|a Deckert, Jürgen.
|e editor.
|
| 700 |
1 |
|
|a Double, K.
|e editor.
|
| 700 |
1 |
|
|a Koutsilieri, E.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783211735732
|
| 830 |
|
0 |
|a Journal of Neural Transmission. Supplementa ;
|v 72
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-211-73574-9
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
